Table 2.
Substrate/Effector | kassoc (μM−1 s−1) | kdissoc (s−1) |
---|---|---|
CDP/ATP | 163 (7) | 75 (10) |
CDP | 193 (7) | 93 (3) |
ATP | 156 (14) | 86 (10) |
None | 179 (11) | 109 (6) |
dATPa | 0.46 (4), 7 (2) |
50 μM, sufficient to saturate both the specificity- and activity-allosteric binding sites.